Cited by 1,957Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.

The molecular logic of endocannabinoid signalling

Open access

Piomelli, Daniele·2003·Nature Reviews Neuroscience

DOI 10.1038/nrn1247

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/nrn1247

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“1 ), which led eventually to the pharmacological identification of cannabinoid-sensitive sites in the brai”
Background
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Show all 152 references

Research works printed but not linked: 4

Rouyer, M. Sur les medicaments usuels des Egyptiens. Bull. Pharmacie 2, 25 (1810).
O'Shaugnessy, W. B. On the Cannabis indica or Indian hemp. Pharmacol. J. Trans. 2, 594 (1843).
Christison, R. in A Dispensatory, or Commentary on the Pharmacopoeias of Great Britain (and the United States) 971–974 (Lea and Blanchard, Philadelphia, 1848).
Adams, R. Marihuana. Harvey Lect. 37, 168 (1941).

Sorted by citations

Items 201–300 of 1,006

Adenosine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Fuxé, K., Marcellino, D. J., Borroto‐Escuela, D. O., Guescini, M., Fernández‐Dueñas, V., Tanganelli, S., Rivera, A., Ciruela, F., & Agnati, L. F. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00126.x · Cited by 175
Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
Preet, A., Ganju, R. K., & Groopman, J. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210641 · Cited by 179
Presynaptic LTP and LTD of Excitatory and Inhibitory SynapsesPreprint
Castillo, P. E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005728 · Cited by 186
Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice
Häring, M., Marsicano, G., Lutz, B., & Monory, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.021 · Cited by 181
Cannabinoids and cancer: causation, remediation, and palliation
Hall, W., Christie, M. J., & Currow, D. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01711-5 · Cited by 171
A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization
Jung, K., Astarita, G., Zhu, C., Wallace, M., Mackie, K., & Piomelli, D. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037796 · Cited by 170
Self-citation
Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
Steiner, M. S., & Wotjak, C. T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00433-0 · Cited by 174
Intracellular trafficking of anandamide: new concepts for signaling
Maccarrone, M., Dainese, E., & Oddi, S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.008 · Cited by 173
Focus on cannabinoids and synthetic cannabinoids
Boisselier, R. L., Alexandre, J., Lelong‐Boulouard, V., & Debruyne, D. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.563 · Cited by 169
Regulation of food intake by oleoylethanolamide
Verme, J. L., Gaetani, S., Fu, J., Oveisi, F., Burton, K. J., & Piomelli, D. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4494-0 · Cited by 174
Self-citation
Endocannabinoids and traumatic brain injury
Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01343.x · Cited by 167
The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking
Palazuelos, J., Davoust, N., Julien, B., Hatterer, E., Aguado, T., Mechoulam, R., Benito, C., Romero, J., Silva, A., Guzmán, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707960200 · Cited by 168
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis
Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzmán, M., & Galve‐Roperh, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700678200 · Cited by 170
Frequency-specific and D 2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling
Yin, H. H., & Lovinger, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510797103 · Cited by 166
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway
Cheng, Y.-J., Dong, Z., & Liu, S. (2014) · Pharmacology · doi:10.1159/000362689 · Cited by 171
Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation
Patel, S., & Hillard, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06266.x · Cited by 162
A restricted population of CB 1 cannabinoid receptors with neuroprotective activity
Chiarlone, A., Bellocchio, L., Blázquez, C., Resel, E., Gómez, E. S., Cannich, A., Ferrero, J. J., Sagredo, O., Benito, C., Romero, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400988111 · Cited by 160
Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates
Justinová, Z., Mangieri, R. A., Bortolato, M., Chefer, S. I., Mukhin, A. G., Clapper, J. R., King, A. R., Redhi, G. H., Yaşar, S., Piomelli, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.008 · Cited by 165
Self-citation
The role of the amygdala in the extinction of conditioned fear.
Barad, M., Gean, P., & Lutz, B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.029 · Cited by 168
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
Bermúdez‐Silva, F. J., Viveros, M., McPartland, J. M., & de Fonseca, F. R. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.012 · Cited by 160
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats
Haller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L. V., & Goldberg, S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1494-7 · Cited by 159
Associative Short-Term Synaptic Plasticity Mediated by Endocannabinoids
Brenowitz, S. D., & Regehr, W. G. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.045 · Cited by 159
Common Molecular Pathways Mediate Long-Term Potentiation of Synaptic Excitation and Slow Synaptic Inhibition
Huang, C. S., Shi, S.-H., Ule, J., Ruggiu, M., Barker, L. A., Darnell, R. B., Jan, Y. N., & Jan, L. Y. (2005) · Cell · doi:10.1016/j.cell.2005.07.033 · Cited by 157
Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation
Shonesy, B. C., Bluett, R. J., Ramikie, T. S., Báldi, R., Hermanson, D. J., Kingsley, P. J., Marnett, L. J., Winder, D. G., Colbran, R. J., & Patel, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.001 · Cited by 155
Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala
Patel, S., Kingsley, P. J., Mackie, K., Marnett, L. J., & Winder, D. G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.101 · Cited by 153
“The neuronal eCB signaling system is composed of eCB ligands, including 2-AG and anandamide, their synthetic and catabolic enzymes, and CB1 receptors (Kano et al, 2009; Piomelli, 2003).”
Cannabinoids, endocannabinoids, and cancer
Hermanson, D. J., & Marnett, L. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9318-8 · Cited by 160
The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells
Greenhough, A., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22917 · Cited by 161
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Fernández‐Espejo, E., Viveros, M., Núñez, L., Ellenbroek, B. A., & de Fonseca, F. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1612-6 · Cited by 155
Adolescent exposure to cannabis as a risk factor for psychiatric disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405362 · Cited by 156
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
Scherma, M., Medalie, J., Fratta, W., Vadivel, S. K., Makriyannis, A., Piomelli, D., Mikics, É., Haller, J., Yaşar, S., Tanda, G., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.011 · Cited by 154
Self-citation
Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor
Hebert-Chatelain, E., Reguero, L., Puente, N., Lutz, B., Chaouloff, F., Rossignol, R., Piazza, P.-V., Benard, G., Grandes, P., & Marsicano, G. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.007 · Cited by 151
The endocannabinoid system and psychiatric disorders
Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 151
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D 2 /A 2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease
Tozzi, A., de Iure, A., Filippo, M. D., Tantucci, M., Costa, C., Borsini, F., Ghiglieri, V., Giampà, C., Fusco, F. R., Picconi, B., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4082-10.2011 · Cited by 154
Plasma Levels of the Endocannabinoid Anandamide in Women—A Potential Role in Pregnancy Maintenance and Labor?
Habayeb, O. M. H., Taylor, A. H., Evans, M. D., Cooke, M. S., Taylor, D. J., Bell, S. C., & Konje, J. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0681 · Cited by 151
Genetic Dissection of the Role of Cannabinoid Type-1 Receptors in the Emotional Consequences of Repeated Social Stress in Mice
Dubreucq, S., Matias, I., Cardinal, P., Häring, M., Lutz, B., Marsicano, G., & Chaouloff, F. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.36 · Cited by 158
Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats
Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146
Leptin and the brain: Influences on brain development, cognitive functioning and psychiatric disorders
Farr, O. M., Tsoukas, M. A., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.004 · Cited by 153
TRPV1 channels facilitate glutamate transmission in the striatum
Musella, A., Chiara, V. D., Rossi, S., Prosperetti, C., Bernardi, G., Maccarrone, M., & Centonze, D. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.09.001 · Cited by 146
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Tanaka, M., Sackett, S., & Zhang, Y. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00087 · Cited by 151
Endocannabinoid Signaling Mediates Cocaine-Induced Inhibitory Synaptic Plasticity in Midbrain Dopamine Neurons
Pan, B., Hillard, C. J., & Liu, Q.-S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4033-07.2008 · Cited by 142
Central Nervous System Regulation of Food Intake
Schwartz, M. W. (2006) · Obesity · doi:10.1038/oby.2006.275 · Cited by 150
Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain
Suardíaz, M., Estivill‐Torrús, G., Goicoechea, C., Bilbao, A., & de Fonseca, F. R. (2007) · Pain · doi:10.1016/j.pain.2007.03.008 · Cited by 144
Fever and hypothermia in systemic inflammation
Garami, A., Steiner, A. A., & Romanovsky, A. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00034-3 · Cited by 148
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Cassano, T., Villani, R., Pace, L., Carbone, A., Bukke, V. N., Orkisz, S., Avolio, C., & Serviddio, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00124 · Cited by 156
A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission
Centonze, D., Battista, N., Rossi, S., Mercuri, N. B., Finazzi‐Agrò, A., Bernardi, G., Calabresi, P., & Maccarrone, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300458 · Cited by 145
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors
Casarotto, P. C., Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833b33c5 · Cited by 141
Endocannabinoids and stress
Riebe, C. J. N., & Wotjak, C. T. (2011) · Stress · doi:10.3109/10253890.2011.586753 · Cited by 149
WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
Pamplona, F. A., & Takahashi, R. N. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.026 · Cited by 141
Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
Viveros, M., Marco, E. M., Llorente, R., & López‐Gallardo, M. (2007) · Neural Plasticity · doi:10.1155/2007/52908 · Cited by 151
Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity
Fino, É., Paillé, V., Cui, Y., Morera‐Herreras, T., Deniau, J., & Venance, L. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.188466 · Cited by 141
Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol
Szabó, B., Urbanski, M. J., Bisogno, T., Marzo, V. D., Mendiguren, A., Baer, W. U., & Freiman, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119362 · Cited by 142
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
Blázquez, C., Chiarlone, A., Bellocchio, L., Resel, E., Pruunsild, P., García-Rincón, D., Sendtner, M., Timmusk, T., Lutz, B., Galve‐Roperh, I., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.11 · Cited by 143
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
Massa, F., Storr, M., & Lutz, B. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0698-5 · Cited by 142
Association of marijuana use and the incidence of testicular germ cell tumors
Daling, J. R., Doody, D. R., Sun, X., Trabert, B. L., Weiss, N. S., Chen, C., Biggs, M. L., Starr, J. R., Dey, S. K., & Schwartz, S. M. (2009) · Cancer · doi:10.1002/cncr.24159 · Cited by 147
Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis
Aguado, T., Carracedo, A., Julien, B., Velasco, G., Milman, G., Mechoulam, R., Álvarez, L., Guzmán, M., & Galve‐Roperh, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608900200 · Cited by 140
Endocannabinoids Induce Lateral Long-Term Potentiation of Transmitter Release by Stimulation of Gliotransmission.
Gómez-Gonzalo, M., Navarrete, M., Perea, G., Covelo, A., Martín-Fernández, M., Shigemoto, R., Luján, R., & Araque, A. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu231 · Cited by 126
Minireview: Endocannabinoids and Gonadal Hormones: Bidirectional Interactions in Physiology and Behavior
Gorzalka, B. B., & Dang, S. S. (2011) · Endocrinology · doi:10.1210/en.2011-1643 · Cited by 139
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
Servadio, M., Melancia, F., Manduca, A., di Masi, A., Schiavi, S., Cartocci, V., Pallottini, V., Campolongo, P., Ascenzi, P., & Trezza, V. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.182 · Cited by 144
Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation
Akopian, A. N., Ruparel, N. B., Patwardhan, A. M., & Hargreaves, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1565-06.2008 · Cited by 142
Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats
Nucci, C., Gasperi, V., Tartaglione, R., Cerulli, A., Terrinoni, A., Bari, M., Simone, C. D., Finazzi‐Agrò, A., Morrone, L. A., Corasaniti, M. T., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1355 · Cited by 137
The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling
Haj‐Dahmane, S., & Shen, R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3258-04.2005 · Cited by 136
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins
Oddi, S., Fezza, F., Pasquariello, N., D'Agostino, A., Catanzaro, G., Simone, C. D., Rapino, C., Finazzi‐Agrò, A., & Maccarrone, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.004 · Cited by 140
Cannabis Use and the Risk for Psychosis and Affective Disorders
Sideli, L., Quigley, H., Cascia, C. L., & Murray, R. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1674991 · Cited by 146
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
Cooray, R., Gupta, V. B., & Suphioglu, C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02054-6 · Cited by 146
Differential Regulation of Synaptic Inputs by Constitutively Released Endocannabinoids and Exogenous Cannabinoids
Hentges, S. T., Low, M. J., & Williams, J. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2769-05.2005 · Cited by 136
Listening to the brain: microelectrode biosensors for neurochemicals
Dale, N., Hatz, S., Tian, F., & Llaudet, E. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.05.010 · Cited by 139
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
Zhang, J., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800524200 · Cited by 136
The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction
Lafenêtre, P., Chaouloff, F., & Marsicano, G. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.006 · Cited by 143
In search of the neurobiological substrates for social playfulness in mammalian brains
Siviy, S. M., & Panksepp, J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.006 · Cited by 162
Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ
Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 136
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 146
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease
Jung, K., Astarita, G., Yaşar, S., Vasilevko, V., Cribbs, D. H., Head, E., Cotman, C. W., & Piomelli, D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.012 · Cited by 136
Self-citation
Regulation of neuronal communication by G protein‐coupled receptors
Huang, Y., & Thathiah, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.007 · Cited by 139
Astrocytes in endocannabinoid signalling
Navarrete, M., Díez, A., & Araque, A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0599 · Cited by 139
Mechanisms of induction and maintenance of spike-timing dependent plasticity in biophysical synapse models
Graupner, M. (2010) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2010.00136 · Cited by 132
Alzheimer's disease; taking the edge off with cannabinoids?
Campbell, V. A., & Gowran, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707446 · Cited by 132
Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents
Campolongo, P., Trezza, V., Ratano, P., Palmery, M., & Cuomo, V. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1892-x · Cited by 133
Cannabis and the developing brain: Insights from behavior
Trezza, V., Cuomo, V., & Vanderschuren, L. J. M. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.058 · Cited by 131
CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice
Cannich, A., Wotjak, C. T., Kamprath, K., Hermann, H., Lutz, B., & Marsicano, G. (2004) · Learning & Memory · doi:10.1101/lm.77904 · Cited by 130
Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study
Swift, W., Coffey, C., Degenhardt, L. J., Carlin, J. B., Romaniuk, H., & Patton, G. C. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2010.129056 · Cited by 129
Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration
Mendizabal‐Zubiaga, J., Melser, S., Bénard, G., Ramos, A., Reguero, L., Arrabal, S., Elezgarai, I., Gerrikagoitia, I., Suárez, J., de Fonseca, F. R., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00476 · Cited by 137
The special relationship: glia–neuron interactions in the neuroendocrine hypothalamus
Clasadonte, J., & Prévot, V. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.124 · Cited by 140
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 134
Adenosine–cannabinoid receptor interactions. Implications for striatal function
Ferré, S., Lluı́s, C., Justinová, Z., Quiroz, C., Orrù, M., Navarro, G., Canela, E. I., Franco, R., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00723.x · Cited by 129
The Endocannabinoid System and Neurogenesis in Health and Disease
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296407 · Cited by 129
The thrifty lipids: endocannabinoids and the neural control of energy conservation
DiPatrizio, N. V., & Piomelli, D. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.006 · Cited by 135
Self-citation
Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain
Ma, W., & Quirion, R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.3.307 · Cited by 128
Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
Spanagel, R. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/rspanagel · Cited by 127
Habenular CB1 Receptors Control the Expression of Aversive Memories
Gómez, E. S., Busquets-García, A., Hu, F., Mehidi, A., Cannich, A., Roux, L., Louit, I., Alonso, L., Wiesner, T., Georges, F. E., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.035 · Cited by 127
Safety and Toxicology of Cannabinoids
Sachs, J., McGlade, E., & Yurgelun-Todd, D. A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0380-8 · Cited by 134
The Endocannabinoid System and Energy Metabolism
Bellocchio, L., Cervino, C., Pasquali, R., & Pagotto, U. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01728.x · Cited by 133
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
Corbillé, A.-G., Valjent, E., Marsicano, G., Ledent, C. A., Lutz, B., Hervé, D., & Girault, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3936-06.2007 · Cited by 126
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
Terzian, A. L. B., Drago, F., Wotjak, C. T., & Micale, V. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00049 · Cited by 127
The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
Banister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_144 · Cited by 132
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 137
Tonic Enhancement of Endocannabinoid-Mediated Retrograde Suppression of Inhibition by Cholinergic Interneuron Activity in the Striatum
Narushima, M., Uchigashima, M., Fukaya, M., Matsui, M., Manabe, T., Hashimoto, K., Watanabe, M., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4644-06.2007 · Cited by 127
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126
Endocannabinoid tone versus constitutive activity of cannabinoid receptors
Howlett, A. C., Reggio, P. H., Childers, S. R., Hampson, R. E., Ulloa, N. M., & Deutsch, D. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01364.x · Cited by 126
Endogenous Cannabinoid Signaling through the CB1Receptor Is Essential for Cerebellum-Dependent Discrete Motor Learning
Kishimoto, Y., & Kano, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1236-06.2006 · Cited by 127
D2 dopamine receptor activation facilitates endocannabinoid-mediated LTD of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-PKA signaling
Pan, B., Hillard, C., & Liu, Q.-S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4035-08.2008 · Cited by 112

Authors: Piomelli, D.
Affiliations: University of California, Irvine (US)
Corresponding author: Piomelli, Daniele
ORCID: Piomelli, Daniele
Venue: Nature Reviews Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2003-11
Volume: 4
Issue: 11
Pages: 873-884
ISSN: 1471-003X (ISSN-L)
1471-0048
DOI: 10.1038/nrn1247
OpenAlex: W2080649553
Cited by: 1,957
References: 152
Citations by year: 2026: 39 · 2025: 42 · 2024: 43 · 2023: 50 · 2022: 76 · 2021: 77 · 2020: 81 · 2019: 71 · 2018: 67 · 2017: 79 · 2016: 81 · 2015: 100 · 2014: 100 · 2013: 95 · 2012: 108
FWCI: 9.35
Type: journal article
Language: en
Open access: green
escholarship.org
Licence: cc-by
www.springer.com/tdm (tdm)
Locations: Nature reviews. Neuroscience (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders: National Alliance for Research on Schizophrenia and Depression
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: endocannabinoids, endocannabinoid signaling, CB1 receptor, delta-9-tetrahydrocannabinol, cannabinoid receptors, neurotransmitter release, ion channel modulation, synaptic plasticity, axon terminals
MeSH terms: Animals, Cannabis, gamma-Aminobutyric Acid, Hallucinogens, Humans, Synaptic Transmission, Dronabinol, Signal Transduction, Neurotransmitter Agents, Glutamic Acid, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The molecular logic of endocannabinoid signalling

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks